Oxford Biomedica plc announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was GBP 87.728 million compared to GBP 64.060 million a year ago. Operating loss was GBP 5.694 million compared to GBP 14.467 million a year ago. Net loss was GBP 6.245 million compared to GBP 16.066 million a year ago.